The increasing interest in effective weight management has resulted in considerable research into groundbreaking treatments. Recently , Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist , has shown promising results in clinical trials, imply